Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System.

作者: Ana P Spencer , Marília Torrado , Beatriz Custódio , Sara C Silva-Reis , Sofia D Santos

DOI: 10.3390/PHARMACEUTICS12020192

关键词:

摘要: Central nervous system (CNS) disorders encompass a vast spectrum of pathological conditions and represent growing concern worldwide. Despite the high social clinical interest in trying to solve these pathologies, there are many challenges bridge order achieve an effective therapy. One main obstacles advancements this field that has hampered therapeutic strategies proposed date is presence CNS barriers restrict access brain. However, adequate brain biodistribution neuronal cells specific accumulation targeted site also major hurdles attainment successful treatment. Over last few years, nanotechnology taken step forward towards development therapeutics neurologic diseases different approaches have been developed surpass obstacles. The versatility designed nanocarriers terms physical chemical properties, possibility functionalize them with moieties, resulted improved neurotargeted delivery profiles. With concomitant progress biology research, inspired by nature advantage physiological processes delivery. Here, nanosystems targeting moieties used reported open literature comprehensively reviewed critically discussed, emphasis on most recent bioinspired advances field. Finally, we express our view paramount need be overcome for promising move from bench bedside.

参考文章(254)
A. V. Lakhin, V. Z. Tarantul, L. V. Gening, Aptamers: Problems, Solutions and Prospects Acta Naturae. ,vol. 5, pp. 34- 43 ,(2013) , 10.32607/20758251-2013-5-4-34-43
H Holback, Yoon Yeo, K Park, None, Hydrogel swelling behavior and its biomedical applications Biomedical Hydrogels#R##N#Biochemistry, Manufacture and Medical Applications. pp. 3- 24 ,(2011) , 10.1533/9780857091383.1.3
EP Ivanova, K Bazaka, RJ Crawford, None, Advanced synthetic polymer biomaterials derived from organic sources New Functional Biomaterials for Medicine and Healthcare. pp. 71- 99 ,(2014) , 10.1533/9781782422662.71
Ningya Shi, Ruben J. Boado, William M. Pardridge, Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes Pharmaceutical Research. ,vol. 18, pp. 1091- 1095 ,(2001) , 10.1023/A:1010910523202
Ruxiang Xu, Enqi Bai, Chuanyi Zheng, Chunyang Ma, Kun Yang, Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma. International Journal of Clinical and Experimental Medicine. ,vol. 8, pp. 1658- 1668 ,(2015)
Philippe G Aftimos, Bojana Milojkovic-Kerklaan, Véronique Diéras, Sevilay Altintas, Carey Anders, Monica Arnedos, Hans Gelderblom, Patricia Soetekouw, Werner Gladdines, Pieter Gaillard, Carlos de Sousa, Agnes Jager, Myra van Linde, Ahmad Awada, Jan Schellens, Dieta Brandsma, Abstract P6-16-04: Phase 1/2a study of glutathione PEGylated liposomal doxorubicin (2B3-101) in breast cancer patients with brain metastases Cancer Research. ,vol. 75, ,(2015) , 10.1158/1538-7445.SABCS14-P6-16-04
Josef Jampilek, Kamil Zaruba, Michal Oravec, Martin Kunes, Petr Babula, Pavel Ulbrich, Ingrid Brezaniova, Radka Opatrilova, Jan Triska, Pavel Suchy, Preparation of silica nanoparticles loaded with nootropics and their in vivo permeation through blood-brain barrier. BioMed Research International. ,vol. 2015, pp. 812673- 812673 ,(2015) , 10.1155/2015/812673
Indu Singh, Rajan Swami, Deep Pooja, Manish Kumar Jeengar, Wahid Khan, Ramakrishna Sistla, Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting Journal of Drug Targeting. ,vol. 24, pp. 212- 223 ,(2016) , 10.3109/1061186X.2015.1068320
Sahil P. Chaplot, Ilva D. Rupenthal, Dendrimers for gene delivery--a potential approach for ocular therapy? Journal of Pharmacy and Pharmacology. ,vol. 66, pp. 542- 556 ,(2014) , 10.1111/JPHP.12104
Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham, Matthew Feinsod, David R. Guyer, Pegaptanib for Neovascular Age-Related Macular Degeneration The New England Journal of Medicine. ,vol. 351, pp. 2805- 2816 ,(2004) , 10.1056/NEJMOA042760